Overview

To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis

Status:
Unknown status
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
Toxoplasmosis, an intra cellular parasite, is a very important cause of chorioretinitis. The goal of treatment is arresting multiplication of the parasite in its inflammatory active phase. In this study the investigators try to compare the efficacy of the classic regimen (Pyrimethamine-Sulfadiazine + Prednisolon) with intravitreal Clindamycin & Dexamethasone.
Phase:
Phase 3
Details
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Treatments:
BB 1101
Clindamycin
Clindamycin palmitate
Clindamycin phosphate
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Pyrimethamine
Sulfadiazine